Search research articles
Contact Us
Filters
Showing results (41-50 of 357) with videos related to
Page
of 36
Sort By:
Breast Cancer Research and Treatment
|
October 26, 2005
Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance
Mitch Dowsett, Robert I Nicholson, Richard J Pietras
Dermatology (Basel, Switzerland)
|
January 1, 1994
Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers
D Czarnecki, B Tait, I Nicholson, et al.
Physics in Medicine and Biology
|
August 14, 1998
Multimodality magnetic resonance systems for studying free radicals in vivo
S J McCallum, I Nicholson, D J Lurie
British Journal of Cancer
|
April 20, 2004
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
C K Osborne, A Wakeling, R I Nicholson
The New England Journal of Medicine
|
March 12, 1992
Skin cancer and HLA antigens
D Czarnecki, J Zalcberg, I Nicholson, et al.
Cancer Surveys
|
January 1, 1986
Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer
R I Nicholson, K J Walker, P Davies
Endocrinology
|
December 1, 1979
Effects of estradiol and the antiestrogen tamoxifen on steroid hormone receptor concentration and nuclear ribonucleic acid polymerase activities in rat uteri
P Davies, J S Syne, R I Nicholson
Journal of the American Academy of Dermatology
|
April 1, 1991
Multiple basal cell carcinomas and HLA frequencies in southern Australia
D Czarnecki, A Lewis, I Nicholson, et al.
European Urology
|
January 1, 1997
Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer
K Griffiths, M S Morton, R I Nicholson
Dermatology (Basel, Switzerland)
|
January 1, 1995
No HLA association with the early development of a single basal cell carcinoma
D Czarnecki, I Nicholson, B Tait, et al.
Page
of 36
Search research articles
Search
Showing results (41-50 of 357) with videos related to
Sort By:
Page
of 36
Breast Cancer Research and Treatment
|
October 26, 2005
Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance
Mitch Dowsett, Robert I Nicholson, Richard J Pietras
Dermatology (Basel, Switzerland)
|
January 1, 1994
Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers
D Czarnecki, B Tait, I Nicholson, et al.
Physics in Medicine and Biology
|
August 14, 1998
Multimodality magnetic resonance systems for studying free radicals in vivo
S J McCallum, I Nicholson, D J Lurie
British Journal of Cancer
|
April 20, 2004
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
C K Osborne, A Wakeling, R I Nicholson
The New England Journal of Medicine
|
March 12, 1992
Skin cancer and HLA antigens
D Czarnecki, J Zalcberg, I Nicholson, et al.
Cancer Surveys
|
January 1, 1986
Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer
R I Nicholson, K J Walker, P Davies
Endocrinology
|
December 1, 1979
Effects of estradiol and the antiestrogen tamoxifen on steroid hormone receptor concentration and nuclear ribonucleic acid polymerase activities in rat uteri
P Davies, J S Syne, R I Nicholson
Journal of the American Academy of Dermatology
|
April 1, 1991
Multiple basal cell carcinomas and HLA frequencies in southern Australia
D Czarnecki, A Lewis, I Nicholson, et al.
European Urology
|
January 1, 1997
Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer
K Griffiths, M S Morton, R I Nicholson
Dermatology (Basel, Switzerland)
|
January 1, 1995
No HLA association with the early development of a single basal cell carcinoma
D Czarnecki, I Nicholson, B Tait, et al.
Page
of 36